FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896543321> ?p ?o ?g. }

• W2896543321 endingPage "235" @default.
• W2896543321 startingPage "229" @default.
• W2896543321 abstract "Philadelphia chromosome-negative (Ph−) relapsed or refractory (R/R) B-cell precursor acute lymphoblastic leukaemia (ALL) is rare, and information on its impact on healthcare systems is scarce. To quantify the time and reimbursement associated with hospitalisations of patients with R/R ALL in a Spanish hospital. Retrospective review of medical charts identified patients aged ≥ 18 years with Ph− R/R ALL hospitalised between 1998 and 2014. Data were collected from the date of first diagnosis of R/R ALL (index) until death or loss to follow-up. The primary endpoint was the proportion of time hospitalised during chemotherapy. Reimbursement associated with hospitalisations (including associated chemotherapy) was also assessed. Thirty-two patients were eligible for inclusion. Their median age was 41 years, and 50% had a first remission duration of ≤ 1 year; 34% had undergone allogeneic haematological stem-cell transplantation (alloHSCT). Overall, 31 patients had received intensive salvage chemotherapy, during which there were 42 hospitalisations (mean 1.4/patient; mean duration 26 days). Patients spent a mean of 71% of the chemotherapy period in hospital. Total mean reimbursement was €26,417 per patient, almost all (€25,723) attributable to inpatient stays (€18,986/hospitalisation). From the index date to death or loss to follow-up (excluding alloHSCT-related hospitalisations), there were 80 hospitalisations (mean duration 24 days); mean reimbursement was €16,692 per hospitalisation and €41,730 per patient. AlloHSCT (n = 8) involved 18 hospitalisations (mean reimbursement €39,782/hospitalisation; €89,510/patient). Data from this sample of patients suggest that hospitalisations in R/R ALL are lengthy and associated with high costs in Spain." @default.
• W2896543321 created "2018-10-26" @default.
• W2896543321 creator A5003682435 @default.
• W2896543321 creator A5007638405 @default.
• W2896543321 creator A5008004148 @default.
• W2896543321 creator A5008594899 @default.
• W2896543321 creator A5009781859 @default.
• W2896543321 creator A5011914281 @default.
• W2896543321 creator A5017341923 @default.
• W2896543321 creator A5030067333 @default.
• W2896543321 creator A5030893605 @default.
• W2896543321 creator A5040307230 @default.
• W2896543321 creator A5067166918 @default.
• W2896543321 creator A5074423796 @default.
• W2896543321 creator A5074938601 @default.
• W2896543321 creator A5077525322 @default.
• W2896543321 date "2018-10-15" @default.
• W2896543321 modified "2023-09-26" @default.
• W2896543321 title "Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain" @default.
• W2896543321 cites W1693855124 @default.
• W2896543321 cites W1848817487 @default.
• W2896543321 cites W2076121796 @default.
• W2896543321 cites W2124890579 @default.
• W2896543321 cites W2167918580 @default.
• W2896543321 cites W2260161190 @default.
• W2896543321 cites W2314541438 @default.
• W2896543321 cites W2329186770 @default.
• W2896543321 cites W2345078020 @default.
• W2896543321 cites W2397604815 @default.
• W2896543321 cites W2419639370 @default.
• W2896543321 cites W2470891258 @default.
• W2896543321 cites W2516611622 @default.
• W2896543321 cites W2591709377 @default.
• W2896543321 cites W2594087813 @default.
• W2896543321 doi "https://doi.org/10.1007/s41669-018-0098-8" @default.
• W2896543321 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6533337" @default.
• W2896543321 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30324566" @default.
• W2896543321 hasPublicationYear "2018" @default.
• W2896543321 type Work @default.
• W2896543321 sameAs 2896543321 @default.
• W2896543321 citedByCount "3" @default.
• W2896543321 countsByYear W28965433212018 @default.
• W2896543321 countsByYear W28965433212021 @default.
• W2896543321 countsByYear W28965433212022 @default.
• W2896543321 crossrefType "journal-article" @default.
• W2896543321 hasAuthorship W2896543321A5003682435 @default.
• W2896543321 hasAuthorship W2896543321A5007638405 @default.
• W2896543321 hasAuthorship W2896543321A5008004148 @default.
• W2896543321 hasAuthorship W2896543321A5008594899 @default.
• W2896543321 hasAuthorship W2896543321A5009781859 @default.
• W2896543321 hasAuthorship W2896543321A5011914281 @default.
• W2896543321 hasAuthorship W2896543321A5017341923 @default.
• W2896543321 hasAuthorship W2896543321A5030067333 @default.
• W2896543321 hasAuthorship W2896543321A5030893605 @default.
• W2896543321 hasAuthorship W2896543321A5040307230 @default.
• W2896543321 hasAuthorship W2896543321A5067166918 @default.
• W2896543321 hasAuthorship W2896543321A5074423796 @default.
• W2896543321 hasAuthorship W2896543321A5074938601 @default.
• W2896543321 hasAuthorship W2896543321A5077525322 @default.
• W2896543321 hasBestOaLocation W28965433211 @default.
• W2896543321 hasConcept C121332964 @default.
• W2896543321 hasConcept C126322002 @default.
• W2896543321 hasConcept C142424586 @default.
• W2896543321 hasConcept C160735492 @default.
• W2896543321 hasConcept C162324750 @default.
• W2896543321 hasConcept C187212893 @default.
• W2896543321 hasConcept C194828623 @default.
• W2896543321 hasConcept C195910791 @default.
• W2896543321 hasConcept C2776694085 @default.
• W2896543321 hasConcept C2779703844 @default.
• W2896543321 hasConcept C50522688 @default.
• W2896543321 hasConcept C71924100 @default.
• W2896543321 hasConcept C87355193 @default.
• W2896543321 hasConceptScore W2896543321C121332964 @default.
• W2896543321 hasConceptScore W2896543321C126322002 @default.
• W2896543321 hasConceptScore W2896543321C142424586 @default.
• W2896543321 hasConceptScore W2896543321C160735492 @default.
• W2896543321 hasConceptScore W2896543321C162324750 @default.
• W2896543321 hasConceptScore W2896543321C187212893 @default.
• W2896543321 hasConceptScore W2896543321C194828623 @default.
• W2896543321 hasConceptScore W2896543321C195910791 @default.
• W2896543321 hasConceptScore W2896543321C2776694085 @default.
• W2896543321 hasConceptScore W2896543321C2779703844 @default.
• W2896543321 hasConceptScore W2896543321C50522688 @default.
• W2896543321 hasConceptScore W2896543321C71924100 @default.
• W2896543321 hasConceptScore W2896543321C87355193 @default.
• W2896543321 hasIssue "2" @default.
• W2896543321 hasLocation W28965433211 @default.
• W2896543321 hasLocation W28965433212 @default.
• W2896543321 hasLocation W28965433213 @default.
• W2896543321 hasLocation W28965433214 @default.
• W2896543321 hasOpenAccess W2896543321 @default.
• W2896543321 hasPrimaryLocation W28965433211 @default.
• W2896543321 hasRelatedWork W2068316626 @default.
• W2896543321 hasRelatedWork W2110818089 @default.
• W2896543321 hasRelatedWork W2351796763 @default.
• W2896543321 hasRelatedWork W2351985199 @default.
• W2896543321 hasRelatedWork W2403502999 @default.

• next